Novartis Investigative Site

La Louvière 7100

0 studies enrolling now · 6 studies all time

What they study most

Anemia, Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Chronic Heart Failure With Reduced Ejection Fraction, Chronic Myeloid Leukemia, Heart Failure With Reduced Ejection Fraction, Hemosiderosis, Type 2 Diabetes Mellitus

Studies at this site

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early
• Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia — NO_LONGER_AVAILABLE
• Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients — Completed